Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfimeprase in Acute Peripheral Arterial Occlusion (NAPA-3)
NCT00338585Phase 3Terminated
- Sponsor
- Oruka Therapeutics
- Start
- Apr 2006
- Primary completion
- Mar 2007
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of alfimeprase in acute peripheral arterial occlusion (APAO), sponsored by Oruka Therapeutics. Started Apr 2006; status: terminated.
02
Drugs
alfimeprase
03
Conditions
acute peripheral arterial occlusion (APAO)
Beyond the preview
Go deeper on NCT00338585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338585.